Clinical Trials Directory

Trials / Terminated

TerminatedNCT03922958

Immunoparalysis in Acute Kidney Injury After Cardiac Surgery

Status
Terminated
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Infection and sepsis are common after acute kidney injury (AKI) and increase mortality. In this study, the investigators will determine whether patients with acute kidney injury after cardiac surgery have immunosuppression as judged by blood markers of immunoparalysis.

Detailed description

Immunoparalysis is an immunosuppressed state that occurs after a wide variety of insults including sepsis and cardiopulmonary bypass surgery. Due to the impaired infection fighting ability, patients with immunoparalysis are at risk of subsequent infection which can increase mortality. Immunoparalysis can be measured by two methods: 1) ex vivo endotoxin stimulation and 2) blood monocyte HLA-DR levels. Since sepsis is also a known complication of Acute Kidney Injury(AKI), the investigators hypothesize that AKI is a risk factor for immunoparalysis. The investigators plan to look at these blood factors of immune function from patients before and 3 days following cardiac surgery. Urine will also be collected from the patients before their surgery as well as the 3 days following for AKI biomarker measurement. This prospective cohort will enroll 300 patients and determine the duration and severity of immunoparalysis among patients who develop AKI and those who do not develop AKI.

Conditions

Timeline

Start date
2019-02-22
Primary completion
2022-05-30
Completion
2022-05-30
First posted
2019-04-22
Last updated
2023-02-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03922958. Inclusion in this directory is not an endorsement.